36577130|t|Atrial Natriuretic Peptide Associated with Cardiovascular Diseases Inhibits Amyloid-beta Aggregation via Cross-Seeding.
36577130|a|Both cardiovascular diseases (CVDs) and Alzheimer's disease (AD) share some common risk factors (e.g., age, obesity, oxidative stress, inflammation, hypertension) that contribute to their overlapping pathogenesis, indicating a "head-to-heart" pathological connection between CVDs and AD. To explore this potential connection at the protein level, we study the potential cross-seeding (heterotypic interactions) between CVD-associated atrial natriuretic peptide (ANP) and AD-associated beta-amyloid (Abeta). Collective aggregation and cell assays demonstrate the cross-seeding of ANP with different Abeta species including monomers, oligomers, and fibrils with high binding affinity (KD = 1.234-1.797 muM) in a dose-dependent manner. Such ANP-induced cross-seeding also modifies the Abeta aggregation pathway, fibril morphology, and cell deposition pattern by inhibiting Abeta fibrillization from small aggregates, disassembling preformed Abeta fibrils, and alleviating Abeta-associated cytotoxicity. Finally, using transgenic C. elegans worms that express the human muscle-specific Abeta1-42, ANP can also effectively delay Abeta-induced worm paralysis, decrease Abeta plaques in worm brains, and reduce reactive oxygen species (ROS) production, confirming its in vivo inhibition ability to prevent neurodevelopmental toxicity in worms. This work discovers not only a new cross-seeding system between the two disease-related proteins but also a new finding that ANP possesses a new biological function as an Abeta inhibitor in the nonaggregated state.
36577130	0	26	Atrial Natriuretic Peptide	Gene	4878
36577130	43	66	Cardiovascular Diseases	Disease	MESH:D002318
36577130	76	88	Amyloid-beta	Gene	351
36577130	125	148	cardiovascular diseases	Disease	MESH:D002318
36577130	150	154	CVDs	Disease	MESH:D002318
36577130	160	179	Alzheimer's disease	Disease	MESH:D000544
36577130	181	183	AD	Disease	MESH:D000544
36577130	228	235	obesity	Disease	MESH:D009765
36577130	255	267	inflammation	Disease	MESH:D007249
36577130	269	281	hypertension	Disease	MESH:D006973
36577130	395	399	CVDs	Disease	MESH:D002318
36577130	404	406	AD	Disease	MESH:D000544
36577130	539	542	CVD	Disease	
36577130	554	580	atrial natriuretic peptide	Gene	4878
36577130	582	585	ANP	Gene	4878
36577130	591	593	AD	Disease	MESH:D000544
36577130	619	624	Abeta	Gene	351
36577130	699	702	ANP	Gene	4878
36577130	718	723	Abeta	Gene	351
36577130	858	861	ANP	Gene	4878
36577130	902	907	Abeta	Gene	351
36577130	990	995	Abeta	Gene	351
36577130	1058	1063	Abeta	Gene	351
36577130	1089	1094	Abeta	Gene	351
36577130	1106	1118	cytotoxicity	Disease	MESH:D064420
36577130	1146	1156	C. elegans	Species	328850
36577130	1157	1162	worms	Species	
36577130	1180	1185	human	Species	9606
36577130	1213	1216	ANP	Gene	4878
36577130	1244	1249	Abeta	Gene	351
36577130	1263	1272	paralysis	Disease	MESH:D010243
36577130	1283	1288	Abeta	Gene	351
36577130	1324	1347	reactive oxygen species	Chemical	MESH:D017382
36577130	1349	1352	ROS	Chemical	MESH:D017382
36577130	1419	1446	neurodevelopmental toxicity	Disease	MESH:D064420
36577130	1450	1455	worms	Species	
36577130	1582	1585	ANP	Gene	4878
36577130	1628	1633	Abeta	Gene	351
36577130	Negative_Correlation	MESH:D064420	4878
36577130	Association	MESH:D000544	4878
36577130	Association	MESH:D010243	4878
36577130	Negative_Correlation	351	4878
36577130	Positive_Correlation	MESH:D010243	351
36577130	Association	MESH:D002318	351
36577130	Negative_Correlation	MESH:D017382	4878
36577130	Association	MESH:D064420	351
36577130	Association	MESH:D002318	4878
36577130	Association	MESH:D000544	351

